Literature DB >> 23538532

Quality of life of esophagectomized patients: adenocarcinoma versus squamous cell carcinoma.

Maricilda Regina Pereira1, Luiz Roberto Lopes, Nelson Adami Andreollo.   

Abstract

OBJECTIVE: To evaluate and compare the quality of life (QOL) of patients undergoing esophagectomy for treatment of adenocarcinoma of the esophagogastric junction and squamous cell carcinoma.
METHODS: We conducted a cross-sectional study in postoperative patients submitted to esophagectomy for adenocarcinoma of the esophagogastric junction (ACA) and squamous cell carcinoma (SCC), using the SF-36 questionnaire applied in 24 patients (10 ACAs and 14 SCCs), from the 5th months postoperatively, including clinical symptoms and weight change.
RESULTS: The assessment of QOL showed the best functional capacity (p = 0.018) in the ACA group. There was a correlation between the fields "mental health" and "Role of Emotions" (p = 0.003) and between "pain" and "physical aspects limitation" (p = 0.003) in both histological types. Weight loss was greater in ACA (45.9 kg), with no significant difference between current BMI (p> 0.66). Dysphagia was reported by 83.3% of patients, anorexia by 58.3%, chewing difficulty by 42%, nausea and vomiting by 41.7% and diarrhea by 29.2%, with no correlation with QOL reported (p> 0.05).
CONCLUSION: The highest score for functional capacity indicates that ACA patients were able to perform all types of physical activity, including the more demanding, at a higher level than patients with SCC. Some symptoms persisted postoperatively, but did not affect the quality of life of patients.

Entities:  

Mesh:

Year:  2013        PMID: 23538532     DOI: 10.1590/s0100-69912013000100002

Source DB:  PubMed          Journal:  Rev Col Bras Cir        ISSN: 0100-6991


  1 in total

1.  PROGNOSTIC FACTORS AND SURVIVAL ANALYSIS IN ESOPHAGEAL CARCINOMA.

Authors:  Francisco Tustumi; Cintia Mayumi Sakurai Kimura; Flavio Roberto Takeda; Rodrigo Hideki Uema; Rubens Antônio Aissar Salum; Ulysses Ribeiro-Junior; Ivan Cecconello
Journal:  Arq Bras Cir Dig       Date:  2016 Jul-Sep
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.